发明授权
- 专利标题： ORALLY ACTIVE SALTS WITH TYROSINE KINASE ACTIVITY
- 专利标题（中）： 口服活性的盐具有酪氨酸激酶活性
-
申请号： EP01987742.2申请日： 2001-10-17
-
公开(公告)号： EP1328519B1公开(公告)日： 2005-09-07
- 发明人: FRALEY, Mark, E. , KARKI, Shyam, B. , KIM, Yuntae
- 申请人： Merck & Co., Inc.
- 申请人地址： 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 US
- 专利权人： Merck & Co., Inc.
- 当前专利权人： Merck & Co., Inc.
- 当前专利权人地址： 126 East Lincoln Avenue Rahway, New Jersey 07065-0907 US
- 代理机构： Horgan, James Michael Frederic
- 优先权： US241043P 20001017
- 国际公布： WO2002032861 20020425
- 主分类号： C07D241/04
- IPC分类号： C07D241/04 ; C07D243/06 ; C07D401/04 ; A61K31/4704 ; A61K31/496 ; A61K31/551
摘要：
The present invention relates to orally active salts of compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
公开/授权文献
- EP1328519A2 ORALLY ACTIVE SALTS WITH TYROSINE KINASE ACTIVITY 公开/授权日：2003-07-23
信息查询
